LKC Technologies
Español
Español English Português 日本
  • Productos
    • For Humans
      • RETeval
      • UTAS mf/PERG
      • Sensor Strips
    • For Animals
      • RETevet
      • Request Demo
      • Order Supplies
  • Aplicaciones
    • Pruebas y ERG
      • Electroretinography (ERG)
      • Potencial evocado visual (PEV)
    • Condiciones clínicas
      • Retinopatía diabética
      • Glaucoma
      • Retinal Ischemic Diseases
      • Inherited Retinal Disorders
      • Miscellaneous
    • Aplicaciones en animales
  • Recursos
    • Case Studies
    • eBooks & Reports
    • Webinars
    • Articles
    • Investigación
    • Blog
    • Videos
    • Software
  • Acerca de LKC
    • Vision & Mission
    • Team
    • Clinical Advisors
    • testimonios
    • History
  • Contact
  • Eye Care Customers
  • VET Customers
  • Buy Sensor Strips

Central Retinal Vein Occlusion (CRVO)

Show:

RETeval
Sensor Strips
RETevet
Menú
  • Animal
  • Central Retinal Vein Occlusion
  • Retinopatía diabética
  • Flicker ERG
  • Enfermedades hereditarias de la retina
  • Optic Nerve Disorders
  • Pediatric
  • Photopic Negative Response
  • Sensor Strips
Supernormal-Flicker-ERGs-in-Eyes-With-Central-Retinal-Vein-Occlusion-Clinical-Characteristics-Prognosis-and-Effects-of-Anti-VEGF-Agent

Supernormal Flicker ERGs in Eyes With Central Retinal Vein Occlusion: Clinical Characteristics, Prognosis, and Effects of Anti-VEGF Agent

diciembre 1, 2018
The purpose of the study was to determine the clinical characteristics, prognosis, and effect of anti-vascular endothelial growth factor (VEGF)…
dovepress

Therapeutic effect of dexamethasone implant in retinal vein occlusions resistant to anti-VEGF therapy

mayo 25, 2016
Author(s): Josh Wallsh, Behnam Sharareh, and Ron Gallemore, 2016. Publication: Clinical Ophthalmology Read Report here.
acta-ophth

Flicker electroretinograms before and after intravitreal ranibizumab injection in eyes with central retinal vein occlusion

enero 18, 2015
Author(s): Yasuda, S., S. Kachi, S. Ueno, C. H. Piao, and H. Terasaki. 2015. Publication: Acta Ophthalmologica Scandinavica Foundation, 93(6):e465-8….
  • Productos
    • RETeval
    • UTAS mf/PERG
    • Sensor Strips
    • RETevet
  • PRUEBAS DE ELECTROFISIOLOGÍA
    • Electroretinography (ERG)
    • ERG de campo completo (ffERG)
    • Patrón ERG (PERG)
    • ERG multifocal (mfERG)
    • Potencial evocado visual (PEV)
    • DIRECCIÓN2 Professional Drive, Suite 222
      Gaithersburg, MD 20879 USA
    • TELÉFONO+1 301 840 1992 (US & Canada)
      +358 40 8486625 (International)
    • DISTRIBUIDORES INTERNACIONALES
      • Distribuidores de Dispositivos Médicos
      • Distribuidores de Dispositivos Veterinarios
  • Follow LKC Technologies on LinkedIn
  • Follow LKC Technologies on Facebook
  • Subscribe to LKC Technologies on YouTube
  • Follow LKC Technologies on Instagram
cropped-cropped-LKC_logo_RGB_color_no_tagline_mini_400px.png
© 2025 LKC Technologies, Inc.
  • DECLARACIÓN DE ACCESIBILIDAD
  • TÉRMINOS Y CONDICIONES
  • CERTIFICACIONES
  • POLÍTICA DE PRIVACIDAD
  • CARRERAS

California Proposition 65 information

Prop-65Warning: This product can expose you to chemicals including lead, which is known to the State of California to cause cancer and birth defects or other reproductive harm. For more information go to www.P65Warnings.ca.gov.

Substance Tables:

The table below lists substances which may be contained within LKC’s RETeval and RETevet products. Substances listed as Type 1 are within permissible levels in one or more of LKC’s products. Substances listed as Type 2 are used in the production of some components used in LKC products and may be present at trace levels, but are typically destroyed during processing. 

RETeval and RETevet Devices

Substance CAS # Type Listed as causing:
Nickel 7440-02-0 1 Cancer
Acrylonitrile 107-13-1 2
Ethylbenzine 100-41-4 2
Crystaline Silica 14808-60-7 1
Lead 7439-92-1 1 Cancer Developmental Toxicity Male Reproductive Toxicity Female Reproductive Toxicity
Methylene Chloride 75-09-2 2 Cancer Female Reproductive Toxicity
Bisphenol A 80-05-7 2
N-Hexane  110-54-3 2 Male Reproductive Toxicity